Republic of Korea vs Norway: Previously treated cases tested for RR-/MDR-TB
Republic of Korea
100.0%
in 2024
Norway
100.0%
in 2024
Republic of Korea rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Republic of Korea
- Norway
How they compare
Republic of Korea currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 6 times across 13 shared years of data; in 2011 it was Norway ahead.
Republic of Korea ranks 1st and Norway ranks 1st of 180 countries.
Across the 2 decades both report, Republic of Korea averaged higher in 1 and Norway in 1.
Head to head by decade
| Decade | Republic of Korea | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 60.8% | 5.2% | Norway |
| 2020s | 92.0% | 89.4% | 2.6% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Republic of Korea or Norway?
- Republic of Korea, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Republic of Korea and Norway?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Norway?
- 13 years are reported by both, from 2011 to 2024.
- How do Republic of Korea and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Republic of Korea ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.